The change to open listing on the NL Prescription Drug Program reduces the administrative burden of prescribers by eliminating the special authorization process that had been in place.
Government is expanding prescription coverage for long-acting muscarinic antagonist (LAMAs) inhalers, used in the treatment of Chronic Obstructive Pulmonary Disease. The change to open listing on the NL Prescription Drug Program reduces the administrative burden of prescribers by eliminating the special authorization process that had been in place. This will ensure NLPDP beneficiaries have timely access to these inhalers for the treatment of their COPD.
$12M project at the Curling westside reservoir will pave the way for 300 new houses
Seven young women from the west coast awarded scholarships
Over $35M announced for 10 water and sewer projects on the west coast, including $12M for Curling reservoir
Woman dies from injuries after a single vehicle crash near Bonavista Thursday night
